Press Releases

Date Title and Summary Additional Formats
Toggle Summary "Nature Reviews Drug Discovery" Publishes New Findings on Trial Complexity Based Upon Benchmark Data from Medidata
Analysis Drawn from Medidata's PICAS Database Uncovers a Significant Increase in the Number of Distinct Procedures Impacting Both Trial Cost and Site and Patient Burden Drug Development Sponsors Can Use Data to Benchmark Against Organizational Practices and Help Optimize Protocol Design NEW YORK
View HTML
Toggle Summary Akros Pharma Inc. and Medidata Commemorate 10-year Partnership with Platform Expansion Agreement
Innovative pharmaceutical company leverages Medidata Clinical Cloud ® to accelerate the delivery of new therapies to market NEW YORK --(BUSINESS WIRE)--Nov. 1, 2017-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, announced
View HTML
Toggle Summary Allscripts President Lee Shapiro Joins Medidata Solutions Board of Directors
Global Clinical Trial Technology Company Attracts Key Leader in Healthcare IT NEW YORK --(BUSINESS WIRE)-- Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development solutions, today announced the election of Lee Shapiro to its board of directors.
View HTML
Toggle Summary Aperio Adds Medidata Edge eTMF and CTMS in Expansion Agreement
Leading clinical research organization moves to the industry’s only unified platform to maximize efficiencies and outcomes NEW YORK --(BUSINESS WIRE)--Feb. 13, 2018-- Aperio, a leading clinical research organization (CRO) formerly known as iNNO Clinical Outcomes, has expanded its use of the
View HTML
Toggle Summary Aris Global and Medidata Solutions Partner to Offer Integration of EDC and Safety Reporting
Solution Offers Instant Data Transfer from EDC to Pharmacovigilance & Safety System to Streamline Patient Adverse Event and Reaction Reporting
View HTML
Toggle Summary Array BioPharma Selects Medidata Rave® as Enterprise-Wide Electronic Data Capture Solution
Company Chooses Medidata Due to Superior Product Functionality and Corporate Vision
View HTML
Toggle Summary ASKLEP Joins Medidata Partner Program to Expand Clinical Trial Services in Asia Pacific
Japanese CRO Builds New Services Around Leading Cloud-Based Clinical Research Platform to Enhance Trials, Extend Phase I-IV Services NEW YORK & TOKYO --(BUSINESS WIRE)-- ASKLEP Inc. , a leading Tokyo -based provider of clinical research services, has joined the Medidata Solutions (NASDAQ: MDSO)
View HTML
Toggle Summary Astellas Selects Medidata Solutions as its Standard for Electronic Clinical Trials
One of Japan’s Largest Pharmas Chooses Medidata for Expertise in Global Markets and Unique Feature Functionality, Including Paper Study and Multi-Lingual Capabilities
View HTML
Toggle Summary Australia NHMRC Clinical Trials Centre Partners with Medidata to Digitize Cancer Research
Leading Australian clinical trials centre adopts Medidata Clinical Cloud ® to accelerate clinical research SYDNEY & NEW YORK --(BUSINESS WIRE)--Apr. 3, 2018-- Medidata (NASDAQ: MDSO) announced that the National Health and Medical Research Council Clinical Trial Centre (NHMRC CTC), University of
View HTML
Toggle Summary Axcan Pharma Achieves Cost Savings with Medidata Rave
Specialty Pharma Takes EDC Implementation In-House to Further Increase Trial Efficiencies and Contain Costs
View HTML

Investor Contact

Betsy Frank
+1 917 522 4620
bfrank@mdsol.com